Allspring Global Investments
SANA icon

Allspring Global Investments’s Sana Biotechnology SANA Stock Holding History

Allspring Global Investments’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,272
Closed -$22.7K – 2507
2024
Q1 		$22.7K Buy
+2,272
New +$17K ﹤0.01% 2114
2023
Q4 		– Sell
-3,159
Closed -$12.2K – 2667
2023
Q3 		$12.2K Sell
3,159
-18,405
-85% -$98.9K ﹤0.01% 2590
2023
Q2 		$129K Sell
21,564
-4,844
-18% -$27.9K ﹤0.01% 1967
2023
Q1 		$86.4K Sell
26,408
-968
-4% -$3.87K ﹤0.01% 2100
2022
Q4 		$108K Sell
27,376
-131
-0.5% -$641 ﹤0.01% 2049
2022
Q3 		$165K Sell
27,507
-6,207
-18% -$44.8K ﹤0.01% 1882
2022
Q2 		$216K Sell
33,714
-15,377
-31% -$98K ﹤0.01% 1793
2022
Q1 		$405K Buy
49,091
+44,321
+929% +$358K ﹤0.01% 2318
2021
Q4 		$73K Buy
+4,770
New +$92K ﹤0.01% 2804

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments's SANA Position: Q2 2024 in Review

Allspring Global Investments sold out of Sana Biotechnology (SANA) in Q2 2024, closing a stake of 2,272 shares — an estimated $22.7K sold.

Allspring Global Investments first reported a position in SANA in Q4 2021 and held it in 9 quarters. The position peaked at $405K in Q1 2022. 148 funds tracked by Wall St. Rank hold SANA as of Q2 2024.

  • Allspring Global Investments reported no remaining Sana Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 2,272 Sana Biotechnology shares in Q2 2024, an estimated $22.7K.
  • Allspring Global Investments first reported a position in Sana Biotechnology in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's Sana Biotechnology position peaked at $405K in Q1 2022.
  • 148 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.